Anti-I17RD/ IL17RD/ HH18 monoclonal antibody

Anti-I17RD/ IL17RD/ HH18 antibody for FACS & in-vivo assay

Target products collectionGo to IL17RD/IL17RD products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-TA171-Ab-1/ GM-Tg-hg-TA171-Ab-2Anti-Human IL17RD monoclonal antibodyHuman
GM-Tg-rg-TA171-Ab-1/ GM-Tg-rg-TA171-Ab-2Anti-Rat IL17RD monoclonal antibodyRat
GM-Tg-mg-TA171-Ab-1/ GM-Tg-mg-TA171-Ab-2Anti-Mouse IL17RD monoclonal antibodyMouse
GM-Tg-cynog-TA171-Ab-1/ GM-Tg-cynog-TA171-Ab-2Anti-Cynomolgus/ Rhesus macaque IL17RD monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-TA171-Ab-1/ GM-Tg-felg-TA171-Ab-2Anti-Feline IL17RD monoclonal antibodyFeline
GM-Tg-cang-TA171-Ab-1/ GM-Tg-cang-TA171-Ab-2Anti-Canine IL17RD monoclonal antibodyCanine
GM-Tg-bovg-TA171-Ab-1/ GM-Tg-bovg-TA171-Ab-2Anti-Bovine IL17RD monoclonal antibodyBovine
GM-Tg-equg-TA171-Ab-1/ GM-Tg-equg-TA171-Ab-2Anti-Equine IL17RD monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-TA171-Ab-1/ GM-Tg-hg-TA171-Ab-2; GM-Tg-rg-TA171-Ab-1/ GM-Tg-rg-TA171-Ab-2;
GM-Tg-mg-TA171-Ab-1/ GM-Tg-mg-TA171-Ab-2; GM-Tg-cynog-TA171-Ab-1/ GM-Tg-cynog-TA171-Ab-2;
GM-Tg-felg-TA171-Ab-1/ GM-Tg-felg-TA171-Ab-2; GM-Tg-cang-TA171-Ab-1/ GM-Tg-cang-TA171-Ab-2;
GM-Tg-bovg-TA171-Ab-1/ GM-Tg-bovg-TA171-Ab-2; GM-Tg-equg-TA171-Ab-1/ GM-Tg-equg-TA171-Ab-2
Products NameAnti-IL17RD monoclonal antibody
Formatmab
Target NameIL17RD
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-IL17RD benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species I17RD/ IL17RD/ HH18 VLP (virus-like particle) (Products Developing)
    CytokineGM-Tg-g-TA171-Ag-1IL17RD interleukin 17 receptor D (IL17RD) protein


    Target information

    Target IDGM-TA171
    Target NameIL17RD
    Gene ID54756,171463,498576,704650,484719,101096454,782214,100058731
    Gene Symbol and Synonyms2810004A10Rik,HH18,IL-17RD,IL17RD,IL17RLM,mSef,RGD1565237,SEF,Sef-S
    Uniprot AccessionQ8NFM7
    Uniprot Entry NameI17RD_HUMAN
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target, Cytokine Target
    DiseaseN/A
    Gene EnsemblENSG00000144730
    Target ClassificationCytokine Receptor

    The target: IL17RD, gene name: IL17RD, also named as HH18, IL-17RD, IL17RLM, SEF. This gene encodes a membrane protein belonging to the interleukin-17 receptor (IL-17R) protein family. The encoded protein is a component of the interleukin-17 receptor signaling complex, and the interaction between this protein and IL-17R does not require the interleukin. The gene product also affects fibroblast growth factor signaling, inhibiting or stimulating growth through MAPK/ERK signaling. Alternate splicing generates multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jan 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.